about
Herpetic whitlowRosacea: The cytokine and chemokine networkPregnancy after laser-assisted selection of viable spermatozoa before intracytoplasmatic sperm injection in a couple with male primary cilia dyskinesia.Hypopigmented scar formation after application of over-the-counter wart and mole removal cream.Tumor immune escape by the loss of homeostatic chemokine expression.Chemokines in tumor-associated angiogenesis.Bevacizumab as a treatment option for radiation-induced cerebral necrosis.Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy.Clinical image: blonde by prescription.Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient.Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.[Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].Allergy 'sucks': leeches may also be harmful.Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases.Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases.The dire consequences of doping.Doxorubicin induces EGF receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells.The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects.Chloromas.[Perioral dermatitis following treatment with tacrolimus].Images in clinical medicine. Erlotinib-induced hair alterations.Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis.Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus.Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors.[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review][Unilateral laterothoracic exanthema][Juvenile pityriasis rubra pilaris][Febrile ulceronecrotic Mucha-Habermann syndrome]Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects[Eccrine porocarcinoma of the head. Report 3 cases][Multimodal therapy in locally advanced gastric cancer]Skin-sparing intensity-modulated radiotherapy of the breast[Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy]Soft tissue sarcomaPyoderma gangrenosum[Merkel cell carcinoma. Viral genesis and new therapeutic options?][Severe toxic dermatitis after injection lipolysis]
P50
Q24608682-17812615-A8BA-4348-BFE7-571550B4E3D8Q27023344-4E5CE234-4071-4DDA-AAC1-5F3A3A3450E6Q33295465-1CA560D4-9470-4245-8021-D4386ED4E384Q33832292-B29CCF0D-FF95-4B72-A7E8-F53079054B56Q36277205-16E5BC54-1EFC-4F01-8498-4F0477EF00ADQ37608615-FF84ABBF-3B65-4818-BCA6-850C7FF76ED2Q37845201-A8B889DB-3261-4D25-9BB7-09CA8CEDE342Q40367379-A43EEF80-F24F-44B1-A9FF-78C4B276885FQ41940491-C115598B-EF68-4901-8908-FB42DDCAE53BQ42523417-61A4F0F4-2032-49AD-B10A-463820BFCCD4Q42524527-A9677ABD-379F-445D-9902-8A9EFBA1AA2DQ42971114-A9ACF056-B6D1-470E-B579-559B16455A63Q43171368-34F93FF8-6660-4DA8-946B-7A4D594CEE99Q43226822-272B87F5-D337-4E12-BDAC-1C38AF18DE60Q44521284-A7BE46FB-F8CD-4111-A6F4-0B3429678312Q46414301-A13FE65A-CC43-42CD-B862-C644D00ECF90Q46447814-C74758D4-0178-4C2D-B9A7-9B82001BD0C6Q46570381-6BF87D5E-2DA8-4404-89BF-C7095D8AA617Q46578178-3C69CCD3-A9CD-46E7-A328-C8EDAB2CEA79Q46687130-2EB7AC6D-3511-4081-B1E2-2495D9660246Q46704755-F82DB961-76D7-4E28-8DE0-7F2F826B0C8BQ47283342-D7023BC6-8EA5-4FA7-8F97-8BC3E1F67C70Q48270269-348114B3-4B99-49D9-8D46-CA11908060D3Q51598157-26BA20EF-679B-421B-925D-DE187A814AB9Q53174384-FEC2EC6C-D1A4-47D4-B9B3-CCB855D23C66Q53927176-656372ED-5CDE-4213-B374-1C7811879D8EQ54610714-F17C7CD0-98AF-45F4-B20C-8C35037844A5Q57135949-E58B2E16-571C-4E2A-A551-BF5A6A5FC8EBQ80224884-AEAECF69-5EC0-4499-8E09-08DA7CA1B448Q80231018-1B0B60EC-A06D-484F-A910-04BF1B1E5F7DQ81229991-3AC73C54-33B2-44A6-8D8D-9459FF52C328Q81415346-9845113B-87EE-42F0-98DD-DA383D43C245Q81484028-FB955E11-CCA2-47D2-9212-AEDF895D9E42Q82082900-47DFFCBB-46D2-49EB-932B-1B84C173372BQ82294660-7D490EFA-A91D-472C-A699-6B0CFAA1CAB0Q83145645-3584B766-BABB-479F-8A7B-458D957C762BQ83145650-4D36AD02-DC5D-4C6E-A14D-93DBD9EEA374Q83157375-6D5E2334-69E7-42E9-8DE9-3CE527D8DFC8Q83498297-86E3013F-AA2B-4B46-81E0-B0C9B3BC65E4Q83653500-D22D00F6-A072-4065-A2F6-045A7FD10385
P50
description
dermatoloog
@nl
hulumtues
@sq
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Arne Gerber
@ast
Peter Arne Gerber
@en
Peter Arne Gerber
@es
Peter Arne Gerber
@nl
Peter Arne Gerber
@sl
type
label
Peter Arne Gerber
@ast
Peter Arne Gerber
@en
Peter Arne Gerber
@es
Peter Arne Gerber
@nl
Peter Arne Gerber
@sl
prefLabel
Peter Arne Gerber
@ast
Peter Arne Gerber
@en
Peter Arne Gerber
@es
Peter Arne Gerber
@nl
Peter Arne Gerber
@sl
P214
P227
P1053
M-2746-2013
P1153
8889284000
P21
P213
0000 0000 1651 017X
P214
P227
P31
P3829
P496
0000-0003-1657-1863
P569
1977-01-01T00:00:00Z
P734
P735
P7859
viaf-42923531